Top Markets
Coin of the day
Promore Pharma AB (publ) Promore Pharma AB (publ)

Promore Pharma AB (publ)

PROMO
Rank in Stocks #25499
Promore Pharma AB (publ) is a Swedish biopharmaceutical firm dedicated to... Promore Pharma AB (publ) is a Swedish biopharmaceutical firm dedicated to advancing peptide-based drug therapies. The company's development pipeline features PXL01, currently undergoing Phase IIa studies for its potential in preventing post-surgical adhesions and scars, mitigating dermal scarring, and aiding hand tendon repair. Another key asset, LL-37, is engaged in Phase IIb clinical trials to address venous leg ulcers, stimulate the healing of persistent wounds, and treat diabetic foot ulcers. Additionally, Promore Pharma has partnered with Fidia Farmaceutici S.p.A. for the production of hyaluronic acid syringes. Founded in 2002, the company, formerly known as Lipopeptide AB until its rebranding in January 2017, maintains its headquarters in Solna, Sweden.
Share Price
$1.34
Last synced: 2024-02-14
Market Cap
$48.96M
Change (1 day)
-12.94%
Change (1 year)
0.00%
Country
SE
Trade Promore Pharma AB (publ) (PROMO)

Category

Stock split history for Promore Pharma AB (publ) (PROMO)
Promore Pharma AB (publ) stock (symbol: PROMO) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 21, 2026.
One PROMO share bought prior to Aug 21, 2026 would equal to 0 PROMO shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
US